CompuMed (CMPD) Stock Price, News & Analysis

Company Overview

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

Key Stats

• Today's Range: $6.00 to $6.34
• 50-Day Range: $5.85 to $6.95
• 52-Week Range: $1.95 to $6.95
• Volume: 305 shs
• Average Volume: 580 shs
• Market Capitalization: $8.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CompuMed Stock Analysis - MarketRank™

CompuMed scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for CompuMed.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of CompuMed is -42.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of CompuMed is -42.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

CompuMed has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.49% of the float of CompuMed has been sold short.

Short Interest Ratio / Days to Cover

CompuMed has a short interest ratio ("days to cover") of 3.96, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CompuMed has recently decreased by 1.93%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CompuMed does not currently pay a dividend.

Dividend Growth

CompuMed does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for CompuMed this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CompuMed insiders have not sold or bought any company stock.

Percentage Held by Insiders

22.00% of the stock of CompuMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

CompuMed has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 6/10/2026
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:CMPD
• CIK: N/A
• Web: www.compumed.net
• Phone: (310) 258-5000
• Fax: 310-645-5880
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.15)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$60 thousand
• Net Margins: -2.51%
• Pretax Margin: -2.85%
• Return on Equity: -6.47%
• Return on Assets: -4.18%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 2.37
• Quick Ratio: 2.34

Sales & Book Value

• Annual Sales: $7.55 million
• Price / Sales: 1.12
• Cash Flow: $0.55 per share
• Price / Cash Flow: 11.61
• Book Value: $2.34 per share
• Price / Book: 2.71

Miscellaneous

• Outstanding Shares: 1,330,000
• Free Float: 1,037,000
• Market Cap: $8.43 million
• Optionable: Not Optionable
• Beta: -0.50